| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10917897 | Radiotherapy and Oncology | 2015 | 6 Pages |
Abstract
In pT3aN0/NxR1 patients with no adjuvant/neoadjuvant treatment, Gleason Score permits independent prediction of the risk for BCR. These findings could help to estimate and discuss the individual risk for BCR with our patients on an individual basis.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Alexander Karl, Alexander Buchner, Christiane Tympner, Thomas Kirchner, Ute Ganswindt, Claus Belka, Roman Ganzer, Wolf Wieland, Fabian Eder, Ferdinand Hofstädter, David Schilling, Karl-Dietrich Sievert, Arnulf Stenzl, Marcus Scharpf, Falko Fend,